Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Hepatology. 2010 Jul;52(1):197–203. doi: 10.1002/hep.23631

Table 1. Clinical and Laboratory Characteristics of the Study Patients at Entry.

Characteristic Bile Acid Analysis (n= 56 ) No Bile Acid Analysis (n= 94 ) p value



Age, years 41.8 (17.8-75.5) 49.3 (20.3-73.6) 0.0017
Duration of disease, years 0.69 (0.04-7.5) 1.62 (0.005-49.5) 0.09
Female sex, n (%) 23 (41) 41 (44) 0.76
Colitis, n (%) 52 (93) 63 (68) 0.0004
Varices, n (%) 8 (14) 18 (19) 0.36
Histologic stage, n (%)
 I 15 (26) 35 (38) 0.09
 II 20 (35) 20 (22) 0.07
 III 13 (23) 24 (26) 0.54
 IV 10 (18) 13 (14) 0.47
Alkaline phosphatase* 4.0 (1.2-12.5) 3.3 (0.52-26.9) 0.25
Aspartate aminotransferase* 1.6 (0.6-4) 1.9 (0.5-8.0) 0.12
Bilirubin, mg/dL* 0.9 (0.3-4.5) 1 (0.3-7.2) 0.18
Mayo risk score 0.015 [(−1.05)-1.8] 0.58 [(−1.4)-2.4] 0.0015

Data are presented as the median (range) unless otherwise indicated.

*

Values represent multiples of the upper limits of normal.